U.S. FDA OKs first drug to prevent HIV infection
Updated: 2012-07-17 13:43
(English.news.cn)
|
|||||||||||
The U.S. Food and Drug Administration (FDA) on Monday approved Truvada, the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of infection and who may engage in sexual activity with HIV-infected partners.
The daily pill Truvada, made by California-based Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's supposed to be used in combination with safe-sex practices to reduce infection risk.
"Truvada alone shouldn't be used to prevent HIV infection," FDA 's Dr. Debra Birnkrant, said in a media briefing.
The FDA previously approved Truvada to be used in combination with other antiretroviral agents for the treatment of HIV-infected adults and children 12 years or older.
People taking Truvada should be tested for HIV infection every three months, so treatment could begin promptly if an infection has occurred, according to the FDA.
"Today's approval marks an important milestone in our fight against HIV," said FDA Commissioner Margaret Hamburg in a statement. "Every year, about 50,000 U.S. adults and adolescents are diagnosed with HIV infection ... New treatments as well as prevention methods are needed to fight the HIV epidemic in this country."
Related Stories
China to make more efforts in HIV prevention 2012-06-26 23:35
Mobile HIV test van proves efficient in Singapore 2012-06-20 11:30
Obama's health reform 2012-07-13 08:09
Today's Top News
Rescuers race against time for quake victims
Telecom workers restore links
Coal mine blast kills 18 in Jilin
Intl scholarship puts China on the map
More bird flu patients discharged
Gold loses sheen, but still a safe bet
US 'turns blind eye to human rights'
Telecom workers restore links
Hot Topics
Lunar probe , China growth forecasts, Emission rules get tougher, China seen through 'colored lens', International board,
Editor's Picks
All-out efforts to save lives |
Liaoning: China's oceangoing giant |
Poultry industry under pressure |
'Spring' in the air for NGOs? |
Boy set to drive Chinese golf |
Latest technology gets people talking |